Danaher Corporation (DHR) vs Natera, Inc. (NTRA)
- Danaher Corporation DHR 228.87 +1.12%
- Natera, Inc. NTRA 313.22 −13.89%
Danaher Corporation and Natera, Inc. are both Diagnostics & Research companies. Danaher Corporation is the larger, with a market value of $159.2B against $52.4B — 3.0× the size. Natera, Inc. has negative trailing earnings, so its P/E is not meaningful; Danaher Corporation trades at 37.0×. Natera, Inc. grew revenue faster over the last twelve months: 37.4% against 5.52%. Danaher Corporation has the higher net margin (16.9% vs −5.66%) and the higher return on invested capital (4.51% vs −8.35%). Across the 20 metrics below, Danaher Corporation leads on 15 and Natera, Inc. on 5.
Valuation
Profitability
| Metric | DHR | NTRA | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 58.59% | 0.00% | 48.32% |
| Operating margin | 20.38% | (8.95%) | (5.68%) |
| Net margin | 16.91% | (5.66%) | (4.10%) |
| Free cash flow margin | 22.46% | 1.80% | 0.00% |
| Return on equity | 8.27% | (10.55%) | 0.00% |
| Return on assets | 5.00% | (7.21%) | (6.05%) |
| Return on invested capital | 4.51% | (8.35%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack